Nanoparticles: Health effects - Pros and cons

被引:395
作者
Gwinn, Maureen R. [1 ]
Vallyathan, Val [1 ]
机构
[1] NIOSH, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA
关键词
cons; nanoparticle toxicity; nanotechnology; pros;
D O I
10.1289/ehp.8871
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
With the advent of nanotechnology, the prospects for using engineered nanomaterials with diameters of < 100 nm in industrial applications, medical imaging, disease diagnoses, drug delivery, cancer treatment, gene therapy, and other areas have progressed rapidly. The potential for nanoparticles (NPs) in these areas is infinite, with novel new applications constantly being explored. The possible toxic health effects of these NPs associated with human exposure are unknown. Many fine particles generally considered "nuisance dusts" are likely to acquire unique surface properties when engineered to nanosize and may exhibit toxic biological effects. Consequently, the nuisance dust may be transported to distant sites and could induce adverse health effects. In addition the beneficial uses of NPs in drug delivery, cancer treatment, and gene therapy may cause unintentional human exposure. Because of our lack of knowledge about the health effects associated with NP exposure, we have an ethical duty to take precautionary measures regarding their use. In this review we highlight the possible toxic human health effects that can result from exposure to ultrafine particles (UFPs) generated by anthropogenic activities and their cardiopulmonary outcomes. The comparability of engineered NPs to UFPs suggests that the human health effects are likely to be similar. Therefore, it is prudent to elucidate their toxicologic effect to minimize occupational and environmental exposure. Highlighting the human health outcomes caused by UFPs is not intended to give a lesser importance to either the unprecedented technologic and industrial rewards of the nanotechnology or their beneficial human uses.
引用
收藏
页码:1818 / 1825
页数:8
相关论文
共 91 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs [J].
Andresen, TL ;
Davidsen, J ;
Begtrup, M ;
Mouritsen, OG ;
Jorgensen, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1694-1703
[3]   Residual oil fly ash increases the susceptibility to infection and severely damages the lungs after pulmonary challenge with a bacterial pathogen [J].
Antonini, JM ;
Roberts, JR ;
Jernigan, MR ;
Yang, HM ;
Ma, JYC ;
Clarke, RW .
TOXICOLOGICAL SCIENCES, 2002, 70 (01) :110-119
[4]  
ASTON A, 2005, NANOTECH BEAMING NAN
[5]   Concentrated ambient air particles induce vasoconstriction of small pulmonary arteries in rats [J].
Batalha, JRF ;
Saldiva, PHN ;
Clarke, RW ;
Coull, BA ;
Stearns, RC ;
Lawrence, J ;
Krishna Murthy, GG ;
Koutrakis, P ;
Godleski, JJ .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 (12) :1191-1197
[6]  
Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102
[7]   Air pollution and cardiovascular disease - A statement for healthcare professionals from the expert panel on population and prevention science of the American Heart Association [J].
Brook, RD ;
Franklin, B ;
Cascio, W ;
Hong, YL ;
Howard, G ;
Lipsett, M ;
Luepker, R ;
Mittleman, M ;
Samet, J ;
Smith, SC ;
Tager, I .
CIRCULATION, 2004, 109 (21) :2655-2671
[8]   Size-dependent proinflammatory effects of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines [J].
Brown, DM ;
Wilson, MR ;
MacNee, W ;
Stone, V ;
Donaldson, K .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 175 (03) :191-199
[9]   Ultrafine particle deposition and clearance in the healthy and obstructed lung [J].
Brown, JS ;
Zeman, KL ;
Bennett, WD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (09) :1240-1247
[10]   Semiconductor nanocrystals as fluorescent biological labels [J].
Bruchez, M ;
Moronne, M ;
Gin, P ;
Weiss, S ;
Alivisatos, AP .
SCIENCE, 1998, 281 (5385) :2013-2016